• Genetic Technologies Ltd., of Melbourne, Australia, said it executed a settlement and license agreement granting AutoImmun Diagnostika GmbH, of Strassberg, Germany, nonexclusive rights to a number of its patents relating to noncoding DNA technology. Financial terms were not disclosed.